Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

E-ISSN： 1349-7006|106|9|1111-1117

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.9, 2015-09, pp. : 1111-1117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1111-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunological evaluation of peptide vaccination for cancer patients with the HLA‐A26 allele

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1257-1263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using Nanotech Radiopharmaceutical for the Visualization of Sentinel Lymph Nodes in Patients with Cervical Cancer

Advanced Materials Research, Vol. 2015, Iss. 1084, 2015-02 ,pp. : 540-544

Trans Tech Publications

Access to resources Recommend Favorite

Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 397-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA replication stress and cancer chemotherapy

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 264-271

John Wiley & Sons Inc

Access to resources Recommend Favorite